ESTABLISHEDSCIENCEscience-backed 99%

Cellular Signaling And Regulatory Pathways

Quality 80/100100 signals6 source typessince 2025-08-31

What is this

This trend focuses on the intricate world of ubiquitin and metabolite signaling in biological systems. It encompasses research on cellular processes, gene expression, and protein regulation, which are key to understanding various diseases and developing novel therapies.

Why it matters

Advanced understanding in this field is critical for the development of new drug therapies, especially in areas like cancer and neurodegenerative disorders. With increasing investment in biotech research and personalized medicine, breakthroughs in ubiquitin signaling could transform treatment paradigms.

Investment angle

Investors might gain exposure by investing in biotech companies engaged in targeted drug discovery and innovation in proteomics. Early-stage biotech startups, alongside larger pharmaceutical companies with strong R&D pipelines, stand to benefit from advancements in this research.

Sovenyr read

A high-potential, long-term biotech play for risk-tolerant investors. Investability: 7/10

History

Flagged 2025-08-31 · Status ESTABLISHED (since 2026-03-14) · last active 2026-07-28
2026-03-09signals (cumulative): 13 → 1002026-07-28
Y = cumulative signals, X = time. A steep climb means the cluster is actively growing; a flat or abruptly-ending line means momentum is gone.
datesignalsnewsubstance
2026-03-0913100%
2026-03-2048+35100%
2026-03-3051+3100%
2026-04-1156+5100%
2026-04-2157+1100%
2026-05-0267+10100%
2026-05-1577+10100%
2026-05-2582+5100%
2026-06-0584+2100%
2026-06-1685+199%
2026-06-2690+599%
2026-07-0797+799%
2026-07-1797+099%
2026-07-28100+399%

Evidence

The 100 collected signals behind this trend — the 20 most recent, each linking to its primary source.
See the live dataTrack record